Clinical Trials Logo

Chronic Pain clinical trials

View clinical trials related to Chronic Pain.

Filter by:

NCT ID: NCT06000007 Active, not recruiting - Chronic Pain Clinical Trials

Digital Therapeutic for Chronic Pain Feasibility Study

Start date: August 25, 2023
Phase: Phase 3
Study type: Interventional

The investigators will conduct a 2-arm randomized control feasibility study to evaluate: 1) the feasibility of using the mobile app and an optional activity tracker, 2) the feasibility of conducting a 2-arm trial, and 3) estimate the effect size for planning for a larger efficacy trial based on our primary outcomes. The intervention arm will test a mobile app that aims to help people reduce pain interference who have chronic pain, as well as mental health issues with depression and anxiety. Participants in the intervention arm will also have the option to sense health data with a tracker that integrates with the app, which will inform the feasibility of this feature.

NCT ID: NCT05998369 Recruiting - Chronic Pain Clinical Trials

Empowered Relief for Youth

ER-Y
Start date: August 9, 2023
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to examine the feasibility and preliminary efficacy of Empowered Relief for Youth with chronic pain (ER-Y). ER-Y is a single-session pain management class for youth focused on pain science education and teaching self-regulatory skills for pain management based on the evidence-based adult ER class. Feasibility and acceptability of ER-Y will be assessed post-class. Preliminary efficacy will be assessed by administering surveys at baseline, 4-weeks, 8-weeks, and 12-weeks post class.

NCT ID: NCT05997979 Recruiting - Chronic Pain Clinical Trials

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children

CAPSAPED
Start date: March 5, 2024
Phase: Phase 2
Study type: Interventional

This study concerns children aged to 12 to 17-years with local chronic neuropathic pain after trauma or surgery. It is a multicentric randomized controlled superiority trial in parallel arms : - experimental arm: Capsaicin 8% cutaneous patch - controlled arm : Hydrocolloid dressing Treatment with capsaicin application is realized at baseline, and repeated 3 months after the first patch application if needed. Tolerance is assessed during each application and by phone call in following days until stop of cold need. Efficacy is assessed monthly by clinical consultation until the end of the study (month 4).

NCT ID: NCT05997368 Completed - Chronic Pain Clinical Trials

Investigation of the Relationship of Pain Perception and Pain Belief With Age in People With Chronic Lack Pain

Start date: September 1, 2023
Phase:
Study type: Observational

This study was planned to investigate the relationship between pain perceptions and pain beliefs of individuals in different age groups with chronic low back pain and symptom severity.

NCT ID: NCT05991440 Recruiting - Chronic Pain Clinical Trials

Examining Racial and Socioeconomic Differences in Chronic Low Back Pain

ERASED
Start date: April 22, 2024
Phase:
Study type: Observational

The purpose of this research study is to gain a better understanding of how people's racial background and socioeconomic status (e.g., income, education, and employment) impact their experiences of chronic low back pain (cLBP).

NCT ID: NCT05989230 Not yet recruiting - Chronic Pain Clinical Trials

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

Start date: August 2024
Phase: N/A
Study type: Interventional

The purpose of this single-arm trial is to determine the feasibility of emotional awareness and expression therapy (EAET) for individuals with persistent pain following orthopedic trauma. As part of this study, participants will be asked to attend weekly EAET treatment sessions and complete assessments (including pre-treatment, post-treatment, and follow-up) consisting of questionnaires and sensory testing procedures.

NCT ID: NCT05986513 Not yet recruiting - Chronic Pain Clinical Trials

Brain MRI for Knee OA

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

It has been estimated that 300 million people worldwide have osteoarthritis (OA), and this has increased by 97% over the past 25 years. OA is degenerative joint disease that has joint cartilage break down and causes the surrounding bone to change and rub. The pain and loss of mobility experienced by people with knee OA can seriously reduce quality of life, while pain management causes significant healthcare spending. Unfortunately, the pain associated with OA is complex and difficult to treat other than to have a total knee replacement surgery to replace the damaged bone and surrounding tissues with artificial ones. Our research study plans to use advanced magnetic resonance imaging techniques and novel analysis methods to determine if specific parts of the brain are responsible for difficult to describe and diagnose aspects of chronic pain. This study will help us better understand the effects of chronic pain in the brain and the results will help guide future research into new therapeutic options that would focus on relieving the brain dysfunction caused by chronic pain.

NCT ID: NCT05986292 Recruiting - Clinical trials for Osteoarthritis, Knee

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

CPMP
Start date: January 30, 2020
Phase: Phase 2
Study type: Interventional

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific appendices (ISAs). The ISAs may start independently of other ISAs as interventions become available for clinical testing.

NCT ID: NCT05985811 Recruiting - Mood Insomnia Clinical Trials

Ketamine Enhances Analgesia and Mood in Chronic Pain Patients

Start date: February 2, 2018
Phase:
Study type: Observational

Most chronic pain patients have mood disorders. The mood disorders may improve with better analgesia produced by Ketamine injections. A prospective study of patients undergoing interventional pain therapy using Ketamine injections. Pre-injection and post-injection patient data is collected. Pain is measured using numeric pain rating scale, and change in pain score by 2-points is considered significant. Sleep is measured using Likert sleep scale, and change in sleep score by 2-points is considered significant. Anxiety is measured using general anxiety disorder (GAD-7) scale, and change in anxiety score by 4-points is considered significant. Depression is measured using patient health questionnaire (PHQ-9), and change in depression score by 5-points is considered significant.

NCT ID: NCT05981573 Recruiting - Pain, Chronic Clinical Trials

Assessment of Methadone Dose Taken Using Electrochemistry

Start date: June 2024
Phase:
Study type: Observational

Proof of concept: Pilot Study A Pilot, proof of concept, observational study with a long-term goal to develop a minimally invasive wearable Remote Medication Monitor (RMM) that provides continuous, real-time data on methadone levels in interstitial fluid (ISF). An RMM could be used as a medication adherence monitor and would allow for the physician, counselor, patient, or family member to remotely verify that a physician-prescribed dose has been taken.